Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of parkinson patients: Potential treatment to improve insulin-like growth factor-1 function (2018)
Type of ContentJournal Article
- Science: Journal Articles 
Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective through improving IGF-1 function. Parkinson disease patients score lower on Hospital-associated Anxiety and Depression Scale after supplementing blackcurrant anthocyanins (BCA), which may be associated with IGF-1 function. We evaluated the changes of cGP and IGF-1 before and after the supplementation. Methods: Plasma and cerebrospinal fluid (CSF) were collected from 11 male patients before and after 28 day supplementation of BCA. The concentrations of IGF-1, IGF binding protein (IGFBP)-3, and cGP were measured using ELISA and HPLC-MS assays. The presence of cGP in the BCA was evaluated. Results: cGP presented in the BCA. BCA supplementation increased the concentration of cGP (p < 0.01), but not IGF-1 and IGFBP-3 in the CSF. CSF concentration of cGP was correlated with plasma concentration of cGP (R = 0.68, p = 0.01) and cGP/IGF-1 molar ratio (R = 0.66, p = 0.01). The CSF/plasma ratio was high in cGP and low in IGF-1 and IGFBP-3. Conclusion: cGP is a natural nutrient to the BCA. The increased CSF cGP in Parkinson disease patients may result from the central uptake of plasma cGP. Given neurotrophic function, oral availability, and effective central uptake of cGP, the BCA has the potential to be developed to treat neurological conditions with IGF-1 deficiency.
CitationFan D, Alamri Y, Liu K, Macaskill M, Harris P, Brimble M, Dalrymple-Alford J, Prickett T, Menzies O, Laurenson A, Anderson T, Guan J (2018). Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of parkinson patients: Potential treatment to improve insulin-like growth factor-1 function. Nutrients. 10(6). 714-714.
This citation is automatically generated and may be unreliable. Use as a guide only.
KeywordsHumans; Ribes; Fruit; Parkinson Disease; Anthocyanins; Peptides, Cyclic; Insulin-Like Growth Factor I; Insulin-Like Growth Factor Binding Protein 3; Antiparkinson Agents; Treatment Outcome; Time Factors; Aged; Aged, 80 and over; Middle Aged; New Zealand; Male; Biomarkers; cyclic Glycine-Proline (cGP); bioavailability of insulin-like growth factor-1 (IGF-1); blackcurrant anthocyanins; autocrine regulation; cerebrospinal fluid; central uptake
ANZSRC Fields of Research32 - Biomedical and clinical sciences::3209 - Neurosciences::320905 - Neurology and neuromuscular diseases
52 - Psychology::5202 - Biological psychology::520203 - Cognitive neuroscience
52 - Psychology::5202 - Biological psychology::520205 - Psychopharmacology
32 - Biomedical and clinical sciences::3210 - Nutrition and dietetics::321002 - Food properties (incl. characteristics and health benefits)
32 - Biomedical and clinical sciences::3210 - Nutrition and dietetics::321001 - Clinical nutrition
Rights© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Showing items related by title, author, creator and subject.
Supplementation of blackcurrant anthocyanins increased cyclic glycine-proline in the cerebrospinal fluid of Parkinson patients: Potential treatment to improve insulin-like growth factor-1 function Fan D; Alamri Y; Liu K; Harris P; Brimble M; Dalrymple-Alford J; Prickett T; Menzies O; Laurenson A; Anderson T; Guan J; MacAskill M (2018)© 2018 by the authors. Licensee MDPI, Basel, Switzerland. Background: Insulin-like growth factor-1 (IGF-1) function is impaired in Parkinson disease. Cyclic glycine-proline (cGP), a metabolite of IGF-1, is neuroprotective ...
Changes of plasma cGP/IGF-1 molar ratio with age is associated with cognitive status of Parkinson disease Fan D; MacAskill M; Anderson T; Guan J; Dalrymple-Alford, John; Pitcher, Toni (Wiley, 2020)Objective: Cognitive impairment is a common feature of Parkinson disease (PD), for which age is a major contributing factor. Insulin-like growth factor-1 (IGF-1) declines with age and contributes to age-related cognitive ...
Melzer TR; Stark MR; Keenan RJ; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Grenfell S; Horne KL; Young BN; Pascoe MJ; Almuqbel MM; Wang J; Miller DH; Anderson TJ; Marsh, Steven; Dalrymple-Alford, John (Frontiers Media SA, 2019)The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloid, contributes to cognitive decline and dementia in Parkinson's disease (PD) is unresolved. Here, we used Florbetaben PET ...